# Severe Asthma, MepolizumaB and Affect: SAMBA Study

> **NCT04680611** · — · UNKNOWN · sponsor: **University Hospital Southampton NHS Foundation Trust** · enrollment: 120 (estimated)

## Conditions studied

- Severe Eosinophilic Asthma
- Psychological Distress
- Anxiety
- Depression
- Psychological Stress
- Psychological Adjustment
- Psychological Disorder
- Psychosocial Problem
- Psychosocial Stressor
- Psychological
- Emotions
- Emotional Disorder
- Emotional Dysfunction
- Emotional Distress
- Adjustment
- Adjustment, Emotional
- Coping Behavior

## Interventions

- **OTHER:** no study intervention. Patients receive standard clinical care

## Key facts

- **NCT ID:** NCT04680611
- **Lead sponsor:** University Hospital Southampton NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-09
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-10-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04680611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04680611, "Severe Asthma, MepolizumaB and Affect: SAMBA Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04680611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*